{"filing":{"accession_number":"0001628280-26-054459","cik":"0001417663","ticker":"SNWV","company_name":"SANUWAVE Health, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"snwv-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026054459/snwv-20260806.htm"},"events":[{"id":24664,"run_id":22361,"accession_number":"0001628280-26-054459","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a clear earnings release disclosing Q2 2026 financial results for Sanuwave Health, Inc. The press release announces revenue of $9.7 million (down 3% YoY), a net loss of $0.7 million (versus net income of $0.6 million in Q2 2025), and operating loss of $0.3 million (versus operating income of $1.4 million in Q2 2025). The company also withdrew its previously issued fiscal year 2026 guidance due to market conditions and Medicare reimbursement developments. This is material as it discloses significant deterioration in profitability and guidance withdrawal.","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":25302,"accession_number":"0001628280-26-054459","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Q2 2026 financial results for Sanuwave Health, Inc. The press release announces revenue of $9.7 million (down 3% YoY), a net loss of $0.7 million (versus net income of $0.6 million in Q2 2025), and operating loss of $0.3 million (versus operating income of $1.4 million in Q2 2025). The company also withdrew its previously issued fiscal year 2026 guidance due to market conditions and Medicare reimbursement developments. This is material as it discloses significant deterioration in profitability and guidance withdrawal.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:33:39.039111+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25302,"accession_number":"0001628280-26-054459","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Q2 2026 financial results for Sanuwave Health, Inc. The press release announces revenue of $9.7 million (down 3% YoY), a net loss of $0.7 million (versus net income of $0.6 million in Q2 2025), and operating loss of $0.3 million (versus operating income of $1.4 million in Q2 2025). The company also withdrew its previously issued fiscal year 2026 guidance due to market conditions and Medicare reimbursement developments. This is material as it discloses significant deterioration in profitability and guidance withdrawal.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:33:39.039111+00:00","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-08-06"}]}